Sanofi
Holdings as of Jun 30, 2026 · filed Jul 28, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Meiragtx Holdings Plc | $164791427 | 30.86% | — | NEW BUY |
| 2 | Inhibrx Biosciences, Inc. | $109713489 | 20.54% | — | NEW BUY |
| 3 | Novavax | $64814131 | 12.14% | — | NEW BUY |
| 4 | Anaptysbio | $55479398 | 10.39% | — | NEW BUY |
| 5 | Odyssey Therapeutics Inc. | $37268786 | 6.98% | — | NEW BUY |
| 6 | Agomab Therapeutics Nv | $36124586 | 6.76% | — | NEW BUY |
| 7 | Maplight Therapeutics Inc. | $32687549 | 6.12% | — | NEW BUY |
| 8 | First Tracks Biotherapeutics Inc. | $16536970 | 3.10% | — | NEW BUY |
| 9 | Immuneering Corp | $13515709 | 2.53% | — | NEW BUY |
| 10 | Q32 Bio Inc. | $3109617 | 0.58% | — | NEW BUY |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.